Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries chemicals, vaccines, biologics, and drug substances at room temperature. The company was founded in 2017 and is headquartered in Lund, Sweden.
Erhalte tagesaktuelle Insights vom finAgent über ZICCUM AB